NASDAQ : DMRA
Damora Therapeutics, Inc. — Financial statements
Denmark
Last price 21.67 USD (Oct 30, 2026, 2:14 PM EDT) · Market cap 1.34B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 22.30M | 9.69M | 10.50M | 12.69M | 13.00M | 13.74M |
| Research & Development | 74.05M | 26.88M | 6.40M | 23.77M | 48.21M | 38.49M |
| Operating Expenses | 96.35M | 36.56M | 16.90M | 36.46M | 61.21M | 52.23M |
| Operating Income | -96.35M | -36.56M | -16.90M | -36.46M | -61.21M | -52.23M |
| Interest & Investment Income | 8.17M | 1.17M | 914.00K | 1.26M | 1.29M | 1.23M |
| Currency Exchange Gain (Loss) | -84.00K | 18.00K | -197.00K | -1.07M | 319.00K | |
| EBT Excluding Unusual Items | -88.17M | -35.48M | -15.96M | -35.40M | -60.99M | -50.68M |
| Merger & Restructuring Charges | -968.00K | -3.45M | ||||
| Gain (Loss) on Sale of Investments | -70.00K | 431.00K | -636.00K | -1.07M | ||
| Gain (Loss) on Sale of Assets | 64.00K | |||||
| Pretax Income | -262.49M | -209.79M | -21.40M | -38.35M | -61.62M | -51.75M |
| Income Tax Expense | 341.00K | 50.00K | 41.00K | |||
| Net Income | -262.83M | -209.84M | -21.44M | -38.35M | -61.62M | -51.75M |
| Preferred Dividends & Other Adjustments | -21.58M | |||||
| Net Income to Common | -241.25M | -209.84M | -21.44M | -38.35M | -61.62M | -51.75M |
| Shares Outstanding (Basic) | 24.43M | 1.36M | 1.16M | 1.06M | 1.02M | 1.01M |
| Shares Outstanding (Diluted) | 24.43M | 1.36M | 1.16M | 1.06M | 1.02M | 1.01M |
| EPS (Basic) | -9.88 | -153.95 | -18.53 | -36.08 | -60.63 | -51.22 |
| EPS (Diluted) | -9.88 | -153.95 | -18.53 | -36.08 | -60.63 | -51.22 |
| Free Cash Flow | -44.52M | -6.73M | -18.62M | -36.91M | -43.13M | -52.53M |
| Free Cash Flow Per Share | -1.82 | -4.93 | -16.09 | -34.73 | -42.43 | -51.99 |
| EBITDA | -96.33M | -36.54M | -16.88M | -36.19M | -61.16M | -52.21M |
| D&A For EBITDA | 22.00K | 22.00K | 21.00K | 269.00K | 42.00K | 20.00K |
| EBIT | -96.35M | -36.56M | -16.90M | -36.46M | -61.21M | -52.23M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 540.51M | 257.62M | 14.18M | 21.46M | 32.79M | 62.56M |
| Short-Term Investments | 11.69M | 27.44M | 37.63M | |||
| Cash & Short-Term Investments | 540.51M | 257.62M | 14.18M | 33.15M | 60.22M | 100.19M |
| Other Receivables | 880.00K | 899.00K | 881.00K | 1.72M | 1.38M | 2.28M |
| Receivables | 880.00K | 899.00K | 881.00K | 1.72M | 1.38M | 2.28M |
| Prepaid Expenses | 243.00K | 577.00K | 590.00K | 774.00K | 805.00K | 1.73M |
| Other Current Assets | 1.95M | 1.32M | 1.19M | 1.13M | 1.50M | 5.90M |
| Total Current Assets | 543.59M | 260.42M | 16.84M | 36.77M | 63.91M | 110.10M |
| Property, Plant & Equipment | 104.00K | 130.00K | 325.00K | 1.17M | 1.04M | |
| Long-Term Investments | 5.83M | 9.05M | ||||
| Other Long-Term Assets | 48.00K | 163.00K | 1.13M | 2.28M | 2.03M | |
| Total Assets | 543.64M | 260.53M | 17.13M | 38.23M | 73.19M | 122.22M |
| Accounts Payable | 3.48M | 17.66M | 377.00K | 1.70M | 3.35M | 1.53M |
| Accrued Expenses | 13.34M | 719.00K | 321.00K | 1.67M | 6.74M | 2.18M |
| Current Portion of Leases | 15.00K | 12.00K | 183.00K | 476.00K | 399.00K | |
| Other Current Liabilities | 10.72M | 1.67M | 487.00K | 2.27M | 539.00K | 438.00K |
| Total Current Liabilities | 27.55M | 20.07M | 1.20M | 5.83M | 11.11M | 4.54M |
| Long-Term Leases | 53.00K | 61.00K | 66.00K | 328.00K | 448.00K | |
| Other Long-Term Liabilities | 27.00K | 28.00K | 43.00K | |||
| Total Liabilities | 27.58M | 20.15M | 1.30M | 5.90M | 11.44M | 4.99M |
| Additional Paid-In Capital | 931.65M | 310.69M | 291.90M | 288.04M | 279.73M | 273.65M |
| Retained Earnings | -546.32M | -487.36M | -277.52M | -256.08M | -217.74M | -156.11M |
| Comprehensive Income & Other | 732.00K | 802.00K | 97.00K | 380.00K | -244.00K | -320.00K |
| Total Common Equity | 386.06M | -175.87M | 14.47M | 32.33M | 61.75M | 117.22M |
| Shareholders' Equity | 516.06M | 240.38M | 15.83M | 32.33M | 61.75M | 117.22M |
| Total Liabilities & Equity | 543.64M | 260.53M | 17.13M | 38.23M | 73.19M | 122.22M |
| Total Debt | 68.00K | 73.00K | 249.00K | 804.00K | 847.00K | |
| Net Cash (Debt) | 540.51M | 257.56M | 14.10M | 32.90M | 65.25M | 108.39M |
| Net Cash Per Share | 22.13 | 188.96 | 12.19 | 30.96 | 64.20 | 107.27 |
| Filing Date Shares Outstanding | 61.74M | 60.30M | 1.32M | 1.08M | 1.03M | 1.01M |
| Total Common Shares Outstanding | 61.73M | 1.60M | 1.32M | 1.08M | 1.03M | 1.01M |
| Working Capital | 516.04M | 240.36M | 15.64M | 30.94M | 52.80M | 105.56M |
| Book Value Per Share | 6.25 | -110.10 | 10.99 | 29.81 | 60.18 | 116.01 |
| Tangible Book Value | 386.06M | -175.87M | 14.47M | 32.33M | 61.75M | 117.22M |
| Tangible Book Value Per Share | 6.25 | -110.10 | 10.99 | 29.81 | 60.18 | 116.01 |
| Machinery | 108.00K | 107.00K | 107.00K | 419.00K | 223.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -262.83M | -209.84M | -21.44M | -38.35M | -61.62M | -51.75M |
| Depreciation & Amortization | 96.00K | 34.00K | 181.00K | 830.00K | 490.00K | 441.00K |
| Loss (Gain) From Sale of Assets | -64.00K | |||||
| Asset Writedown & Restructuring Costs | 174.31M | 174.31M | ||||
| Loss (Gain) From Sale of Investments | 70.00K | -431.00K | 636.00K | 1.07M | ||
| Stock-Based Compensation | 9.94M | 1.04M | 3.33M | 5.43M | 5.57M | 4.48M |
| Other Operating Activities | 9.37M | 9.37M | 1.90M | 46.00K | 58.00K | 75.00K |
| Change in Accounts Payable | 8.37M | 17.27M | -1.32M | -1.65M | 1.82M | -1.32M |
| Change in Other Net Operating Assets | 16.23M | 1.09M | -1.34M | -2.72M | 10.12M | -5.30M |
| Operating Cash Flow | -44.52M | -6.73M | -18.62M | -36.91M | -42.93M | -52.31M |
| Capital Expenditures | -196.00K | -223.00K | ||||
| Sale of Property, Plant & Equipment | 83.00K | |||||
| Cash Acquisitions | -17.37M | -17.37M | ||||
| Investment in Securities | 11.65M | 22.25M | 12.58M | -47.83M | ||
| Investing Cash Flow | -17.37M | -17.37M | 11.65M | 22.33M | 12.38M | -48.05M |
| Issuance of Common Stock | 346.90M | 33.00K | 3.08M | 707.00K | ||
| Other Financing Activities | -21.44M | -200.00K | -200.00K | |||
| Financing Cash Flow | 592.27M | 266.84M | 2.88M | 507.00K | ||
| Foreign Exchange Rate Adjustments | -77.00K | 705.00K | -317.00K | 384.00K | 264.00K | -917.00K |
| Net Cash Flow | 530.30M | 243.45M | -7.29M | -11.32M | -29.78M | -101.27M |
| Free Cash Flow | -44.52M | -6.73M | -18.62M | -36.91M | -43.13M | -52.53M |
| Free Cash Flow Per Share | -1.82 | -4.93 | -16.09 | -34.73 | -42.43 | -51.99 |
| Levered Free Cash Flow | -15.98M | -3.05M | -10.55M | -21.45M | -19.68M | -33.19M |
| Unlevered Free Cash Flow | -15.98M | -3.05M | -10.55M | -21.45M | -19.68M | -33.19M |
| Cash Income Tax Paid | 5.00K | 5.00K | ||||
| Change in Working Capital | 24.61M | 18.36M | -2.67M | -4.37M | 11.94M | -6.62M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.33B | 36.75M | 6.12M | 19.52M | 29.42M | 76.54M |
| Enterprise Value | 792.97M | 30.56M | -13.52M | -24.19M | -45.64M | -50.15M |
| Last Close Price | 21.60 | 23.01 | 4.65 | 18.00 | 28.75 | 75.75 |
| PB Ratio | 3.45 | 0.15 | 0.39 | 0.60 | 0.48 | 0.65 |
| P/TBV Ratio | 3.45 | 0.42 | 0.60 | 0.48 | 0.65 | |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.05 | -1.07 | -0.89 | -1.02 | -1.06 | -0.93 |
| Net Debt / EBITDA Ratio | 5.61 | 7.05 | 0.84 | 0.91 | 1.07 | 2.08 |
| Net Debt / FCF Ratio | 12.14 | 38.29 | 0.76 | 0.89 | 1.51 | 2.06 |
| Quick Ratio | 19.65 | 12.88 | 12.58 | 5.98 | 5.55 | 22.55 |
| Current Ratio | 19.73 | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 |
| Return on Equity (ROE) | -99.74% | -163.80% | -89.03% | -81.52% | -68.86% | -36.61% |
| Return on Assets (ROA) | -21.61% | -16.46% | -38.15% | -40.90% | -39.15% | -22.22% |
| Return on Capital Employed (ROCE) | -18.70% | -15.20% | -106.00% | -112.50% | -98.60% | -44.40% |
| Earnings Yield | -45.72% | -570.92% | -350.08% | -196.45% | -209.48% | -67.61% |
| FCF Yield | -3.34% | -18.30% | -304.10% | -189.08% | -146.60% | -68.63% |
| Buyback Yield / Dilution | -1,814.32% | -17.79% | -8.87% | -4.58% | -0.58% | -452.45% |